-
effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
July 21, 2014 - Current Page Topic Timeline Jan. 24, 2013 Topic Suggestion Jul. 21, 2014 Research Protocol Jun. 30, 2015 Systematic Review Nov. 3, 2015 Disposition of Comments Report Treatment of Non-metastatic Muscle-invasive Bladder Cancer
Research Protocol Archived July 21, 2014 Download Main Document PDF 854 KB
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
July 21, 2014 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Treatment of Non-metastatic Muscle-invasive Bladder Cancer
I. Background and Objectives for the Systematic Review
Nature and burden of non-metastatic muscle-invasive bladder cancer
Bladder cancer is the fourth most commonly diagnosed cancer…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - Estrogen receptor genotype is associated
with risk of venous thromboembolism
during tamoxifen therapy … Effect of raloxifene on stroke and venous
thromboembolism according to subgroups in
postmenopausal
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - long-term raloxifene
reduces vertebral fractures, but not hip or
nonvertebral fractures, and increases venous … thromboembolism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - long-term raloxifene
reduces vertebral fractures, but not hip or
nonvertebral fractures, and increases venous … thromboembolism
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - For example, guidelines based on a
systematic review of benefits and harms of strategies to prevent venous … thromboembolism
considered prevention of pulmonary embolism as a clinically important outcome, but … The key informants may have different preferences, as noted in the
example of the reports on venous … thromboembolism. 30,31 In these examples, pulmonary embolism
was considered a clinically important … Prevention of venous thromboembolism:
American College of Chest Physicians Evidence-
Based Clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - Source: www.effectivehealthcare.ahrq.gov
Published online: April 20, 2015
Evidence-based Practice Center Systematic Review Protocol
Project Title: Management of Renal Masses and Localized Renal Cancer
Amendment Date applicable: March 2, 2015
(Amendments Details–see Section VII)
I. Background and Objectives f…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
March 21, 2013 - think that this work adequately evaluates the different
progestins and why there may be differences in VTE
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
April 01, 2014 - anastomotic leakage,
planned and unplanned stomas, failed attempts to
restore bowel continuity, and venous … thromboembolism;
health system and resource utilization outcomes, such
as readmissions after surgery
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Estrogen receptor genotype is associated
with risk of venous thromboembolism
during tamoxifen therapy … Effect of raloxifene on stroke and venous
thromboembolism according to subgroups in
postmenopausal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
CER # 15:
Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Original release date
July 6, 2009
Surveillance Report (1st Assessment/cycle 1)
November, 2011
Surveillance Report (2nd Assessment/cycle 2)…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - versus placebo, the association of treatment group
with risk of coronary heart disease, stroke, or venous … thromboembolism did not significantly differ by age,…”
Discussion Public Commenter
#8 (ODP/P2P
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - versus placebo, the association of treatment group
with risk of coronary heart disease, stroke, or venous … thromboembolism did not significantly differ by age,…”
Discussion Public Commenter
#8 (ODP/P2P
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sickle-cell-dental-rapid-response.pdf
July 01, 2024 - Venous thromboembolism prophylaxis in sickle cell disease: a
multicenter cohort study of adolescent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Examples of the latter include venous thromboembolism risk in women taking third
generation over-the-counter
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Examples of the latter include venous thromboembolism risk in women taking third
generation over-the-counter
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
July 28, 2016 - On the other hand, cesarean delivery increases the risk of maternal hemorrhage,
venous thromboembolism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
June 28, 2013 - Disposition of Comments Report for Treatment of Atrial Fibrillation
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Treatment of Atrial Fibrillation
Draft review available for public comment from July 27, 2012 to August 24, 2012.
Suggested citation: A…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
November 01, 2011 - Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth
Effective Health Care Program
Number 35
Research Reports
Attention Deficit Hyperactivity Disorder
Medications and Risk of Serious Cardiovascular
Disease in Children and Youth
William O. Cooper, M.…
-
effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
February 01, 2018 - patients and includes intravenous fluid resuscitation,
electrolyte replacement, and pharmacological venous … thromboembolism prophylaxis.